Spain· ES:04285032IP1
APIDRA 100 UNIDADES/ML,SOLOSTAR SOLUCION INYECTABLE EN PLUMA PRECARGADA
A medicinal product containing insulina glulisina, registered in Spain by Sanofi-Aventis Deutschland Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- insulina glulisina
- Manufacturer
- Sanofi-Aventis Deutschland Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 24, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulina glulisina in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAPIDRASanofi-Aventis Deutschland GmbH, Frankfurt am Main
- United KingdomApidra 100units/ml solution for injection 10ml vialsSanofi
- FinlandApidraSanofi-Aventis Deutschland GmbH
- CanadaAPIDRASANOFI-AVENTIS CANADA INC
- IcelandApidraSanofi-Aventis Deutschland GmbH
- ItalyAPIDRA*1 flaconcino SC 10 ml 100 U/mlSANOFI AVENTIS DEUTSCHL.GMBH
- Japanインスリングルリジン（遺伝子組換え）サノフィ
- NetherlandsApidra 100 Eenheden/ml oplossing voor injectie in injectieflaconSanofi-Aventis Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Apidra, Apidra Solostar
- Liechtenstein · Apidra, Apidra Solostar
- Norway · Apidra, Apidra Solostar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c444bd17-f9e4-4e83-b91e-e84ce6264b66 GET /v1/drugs/c444bd17-f9e4-4e83-b91e-e84ce6264b66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":1786973405000}",
"nregistro": "04285032IP1",
"substance": "insulina glulisina"
}See everything about insulina glulisina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.